Global Pharmaceutical Projects Announced

Cleveland Clinic Plans to Construct Research Building in USA

The stateoftheart facilities will be dedicated to enhance scientific investigations and expanding laboratory research space on its main campus

MaaT Pharma and Skyepharma Construct New Manufacturing Facility in Europe

MaaT Pharma and Skyepharma have successfully completed the construction of Europes largest manufacturing facility dedicated to microbiome ecosystem therapies

Astraea Bioseparations Expands Manufacturing and Warehousing Capacity in Massachusetts, USA

Astraea Bioseparations is expanding its manufacturing and warehousing capacity to support chromatography solutions in Massachusetts, USA

Novo Nordisk Invests US$134 million (DKK 950 million) for New Cell Therapy Facility in Denmark, Europe

Novo Nordisk plans to invest US$134 million DKK 950 million to open worldclass cell facility located at Denmark, Europe

Merck Invests US$29 million (€28 million) to Open Drug Manufacturing Sites in Germany

Merck plans to invest US$29 million 28 million to open two new GMPgrade mRNA drug substance manufacturing sites in Darmstadt and Hamburg, Germany

MSD Invests US$1.18 billion (€1 billion) to Expand Footprint in Ireland

MSD invests US$118 billion 1 billion to expand its facilities in Dunboyne and Carlow, both situated in Ireland

Astellas Pharma Invests US$352 million (€330 million) in State-of-the-Art Facility in Kerry, Ireland

The stateoftheart facility is planned to span approximately 447 acres in size It will consist of a 3storey building with a total floor area of 17,000 square metres, and the buildings footprint will cover approximately 7,300 square metres

Renaissance Lakewood Expands Laboratory Facilities in New Jersey, USA

Renaissance Lakewood expands the capabilities of quality control sprayparticulate laboratory, along with significant upgrades to their analytical and formulation research and development laboratories in New Jersey, USA